Aspiro Pharma Profile
Key Indicators
- Authorised Capital ₹ 415.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 404.15 Cr
as on 14-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 206.91 Cr
as on 14-12-2024
- Satisfied Charges ₹ 46.89 Cr
as on 14-12-2024
- Revenue -44.41%
(FY 2022)
- Profit -170.49%
(FY 2022)
- Ebitda -130.69%
(FY 2022)
- Net Worth 63.16%
(FY 2022)
- Total Assets 63.59%
(FY 2022)
About Aspiro Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 415.00 Cr and a paid-up capital of Rs 404.15 Cr.
The company currently has active open charges totaling ₹206.91 Cr. The company has closed loans amounting to ₹46.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aspiro Pharma Limited India are Srinivas Dakarapu as CFO and Sudershan Pallap as Company Secretary. Bandi Vamsikrishna, Krishnaveni Kura, Chandra Tumuluru, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2014PLC092771
- Company No.
092771
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aspiro Pharma Limited offer?
Aspiro Pharma Limited offers a wide range of products and services, including Content Writing Service, Research Development Services.
Who are the key members and board of directors at Aspiro Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Dakarapu  | CFO | 29-Jun-2017 | Current |
| Sudershan Pallap | Company Secretary | 01-Apr-2021 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Reddy Narsimha | Director | 03-Aug-2024 | Current |
| Bandi Vamsikrishna | Director | 13-Feb-2014 | Current |
| Krishnaveni Kura | Director | 29-Jun-2017 | Current |
| Chandra Tumuluru | Director | 30-Mar-2021 | Current |
| Sudhakar Avuthu | Director | 03-Sep-2022 | Current |
| Mahesh Hassan | Director | 07-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Aspiro Pharma.
Aspiro Pharma Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 44.41% decrease. The company also saw a substantial fall in profitability, with a 170.49% decrease in profit. The company's net worth Soared by an impressive increase of 63.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspiro Pharma?
In 2021, Aspiro Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hetero Marbles Private LimitedActive 27 years 6 monthsBandi Vamsikrishna and Chandra Tumuluru are mutual person
Hetero Labs LimitedActive 35 years 9 monthsBandi Vamsikrishna and Sudershan Pallap are mutual person
- Hetero Biopharma LimitedActive 8 years 3 months
Bandi Vamsikrishna and Chandra Tumuluru are mutual person
- Hetero Wind Power LimitedActive 13 years 11 months
Bandi Vamsikrishna, Sudhakar Avuthu and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Sep 2024 | ₹100.00 Cr | Open |
Others Creation Date: 10 May 2024 | ₹0.90 M | Open |
Others Creation Date: 03 Apr 2024 | ₹105.00 Cr | Open |
How Many Employees Work at Aspiro Pharma?
Aspiro Pharma has a workforce of 408 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspiro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspiro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
